Antisynthetase syndrome – Basic Information

Go back

Antisynthetase syndrome is a rare autoimmune disease where the immune system mistakenly attacks the body, causing widespread inflammation that can affect muscles, joints, lungs, skin, and blood vessels. With fewer than 50,000 people in the United States living with this condition, understanding its symptoms and how it impacts daily life is essential for those affected and their loved ones.

How Common is Antisynthetase Syndrome?

Antisynthetase syndrome is considered a rare disease. Experts estimate that fewer than 50,000 people in the United States have this condition, though the exact number remains uncertain. This is partly because so few cases are reported each year, and some people may never receive an accurate diagnosis if their symptoms are mistaken for other conditions with similar presentations[1].

Worldwide, the condition is estimated to affect between 1 and 3 people per 100,000, according to data from Orphanet. However, precise information about the disease’s prevalence is still limited[2]. The rarity of antisynthetase syndrome can make it challenging for patients to find doctors familiar with the condition and can delay diagnosis.

The syndrome does not affect everyone equally. Women are affected two to three times more often than men[4]. The average age when symptoms first appear is around 50 years old, though the condition can develop at different ages[6].

Research shows that approximately 20 to 25 percent of people diagnosed with dermatomyositis (a condition causing muscle inflammation and skin rashes) or polymyositis (muscle inflammation without skin involvement) also have antisynthetase antibodies in their blood[4]. This overlap highlights how antisynthetase syndrome shares features with other inflammatory muscle diseases.

What Causes Antisynthetase Syndrome?

The exact cause of antisynthetase syndrome remains unknown to medical experts. What researchers do understand is that this condition involves the immune system behaving abnormally. The immune system, which normally protects the body from harmful invaders like bacteria and viruses, mistakenly begins attacking healthy tissues instead[1].

Most people with antisynthetase syndrome have specific autoantibodies (proteins made by the immune system that attack the body’s own tissues) in their blood. These autoantibodies target enzymes called tRNA synthetases, which are essential proteins the body needs to function properly[1]. Think of antibodies as chemical signals your immune system uses to flag harmful substances. In autoimmune diseases, these signals get confused and start marking healthy tissue as dangerous.

The most common antisynthetase antibody is called anti-Jo-1. Other types include anti-PL-7 and anti-PL-12. Several additional antisynthetase antibodies have been identified, though they are much rarer and their implications are not yet well understood. Researchers continue to discover new autoantibodies that may be significant to muscle diseases like antisynthetase syndrome[4].

Why the immune system begins producing these harmful autoantibodies remains unclear. Scientists have not identified specific genetic factors, environmental triggers, or lifestyle habits that definitively cause the condition. The presence of these autoantibodies in blood tests provides strong evidence that someone has antisynthetase syndrome, much like finding remnants after fireworks—you can see the evidence of what happened even if you don’t know exactly when or why it occurred[1].

Risk Factors for Developing Antisynthetase Syndrome

While the underlying cause of antisynthetase syndrome is not known, certain characteristics make some people more likely to develop the condition than others. Understanding these risk factors can help with earlier recognition, though having risk factors does not guarantee someone will develop the disease.

Gender plays a significant role in risk. Women develop antisynthetase syndrome approximately two to three times more frequently than men[4]. The reasons for this gender difference are not fully understood, but it follows a pattern seen in many autoimmune diseases, which generally affect women more often than men.

Age is another important consideration. The condition most commonly begins around age 50, though people younger or older can certainly be affected[6]. This middle-age onset means that people may first notice symptoms during their working years, which can significantly impact their careers and daily activities.

People who already have certain inflammatory muscle conditions may be at higher risk. The syndrome typically affects individuals with dermatomyositis, polymyositis, or necrotizing myopathy (a condition where muscle fibers break down)[4]. Between 20 and 25 percent of people with these muscle diseases have antisynthetase antibodies[4].

Interestingly, patients with antisynthetase syndrome appear to be less likely to experience cancer-associated myositis compared to those with other forms of inflammatory muscle disease. However, some case studies have reported various cancers occurring within 6 to 12 months of diagnosis, so age-appropriate cancer screening is still recommended[4][7].

⚠️ Important
The mortality risk from antisynthetase syndrome itself is not necessarily increased, but the presence of severe interstitial lung disease is most frequently associated with early death. This makes lung involvement a critical factor that requires careful monitoring and aggressive treatment.

Symptoms of Antisynthetase Syndrome

The symptoms someone experiences with antisynthetase syndrome depend on which parts of the body are affected and how severely the immune system has damaged the tissues. Not everyone will have all possible symptoms, and the combination can vary greatly from person to person.

Myositis, which means chronic muscle inflammation, is one of the most common features. About 91 percent of patients display muscle weakness affecting the larger muscles close to the body’s center. This condition causes muscle pain and weakness that can make everyday activities challenging. People may have difficulty climbing stairs, reaching overhead cupboards, or getting up from a seated position. The weakness can range from barely noticeable to substantial and disabling[2][1].

Muscle pain is also prevalent. Between 30 and 89 percent of people with antisynthetase syndrome report persistent muscle tenderness and myalgia (the medical term for muscle pain)[2]. In some cases, myositis can weaken the muscles in the throat that help with swallowing, leading to dysphagia (difficulty swallowing). This complication can increase the risk of food or liquid entering the lungs, potentially causing aspiration pneumonia[1][7].

Interstitial lung disease is another major concern, affecting between 67 and 100 percent of people with antisynthetase syndrome[2]. This condition damages the tissues between the small air sacs in the lungs and the blood vessels around them. The symptoms include shortness of breath, dry cough, fatigue, and chest discomfort. Some people experience these breathing problems early on, while others develop them later as the syndrome progresses[1][2].

In fact, lung disease with cough and shortness of breath represents the most common symptoms[2]. Lung involvement is so significant that it may be the first or only symptom some people experience with antisynthetase syndrome[4]. A recent study found that 42.2 percent of patients with antisynthetase syndrome had pleural effusions (fluid accumulation around the lungs)[2].

Polyarthritis—inflammation affecting five or more joints at the same time—causes joint pain, stiffness, and swelling. The arthritis in antisynthetase syndrome is commonly described as symmetrical (affecting both sides of the body equally) and non-erosive (not wearing away bone), typically affecting the small joints of the hands and feet. This pattern can sometimes mimic rheumatoid arthritis or other inflammatory joint conditions[2][1].

Joint problems occur in about 18 to 55 percent of inflammatory muscle diseases and present as the first symptom in approximately 24 to 66 percent of patients. This early joint involvement can lead to diagnostic delays because doctors may initially suspect other conditions. Hand X-rays may show erosions, calcifications around joints, or partial dislocations in about 50 percent of patients[2].

Skin changes are also characteristic. Mechanic’s hands is a distinctive feature involving thickened, cracked, dry skin on the palms and sides of the fingers. The term comes from how the hands look rough and dirty, similar to those of someone who works with their hands extensively. This condition can be painful and affects about 30 percent of patients[1][7].

Raynaud’s phenomenon causes episodes of reduced blood flow to the fingers and toes, which turn white, then blue, and finally red. These episodes typically happen in response to cold temperatures or emotional stress and can cause numbness and a cold feeling in the affected areas. The nose and ears can also be affected. About 40 percent of people with antisynthetase syndrome experience this condition, which can last several minutes to several hours[4][7].

Some people develop fevers that are not related to fighting off an infection. These unexplained fevers occur in about 20 to 30 percent of patients and may appear at the onset of the disease or return during relapses of the condition[4][7].

Other symptoms can include loss of appetite, weight loss, and extreme fatigue that can significantly alter daily life[6]. The combination of symptoms varies greatly among individuals, and the severity can range from mild to life-threatening, particularly when severe lung disease is present.

Prevention and Early Detection

Because the cause of antisynthetase syndrome is unknown, there are currently no specific measures that can prevent the disease from developing. However, early recognition of symptoms and prompt medical attention can make a significant difference in outcomes.

Anyone noticing new symptoms such as persistent joint pain, unexplained changes to their skin, progressive muscle weakness, or breathing difficulties should visit a healthcare provider promptly[1]. Early diagnosis is crucial for appropriate and timely treatment, especially when lung involvement is present. Seeing a doctor with experience in inflammatory muscle diseases is highly recommended[6].

For people already diagnosed with antisynthetase syndrome, maintaining regular follow-up appointments is essential. Healthcare providers need to monitor for disease progression, particularly the development or worsening of interstitial lung disease, which contributes significantly to illness and mortality in this condition[3].

Vaccination is an important preventive measure for people with antisynthetase syndrome. Because treatment involves medications that suppress the immune system, staying current with recommended vaccinations helps protect against preventable infections. However, timing and types of vaccines should be discussed with healthcare providers, as some vaccines may be less effective or contraindicated depending on the medications being used[4].

Maintaining a healthy lifestyle supports overall wellbeing for those living with the condition. Physical and occupational therapy can help strengthen muscles and maintain function, especially when muscle weakness makes exercise painful or difficult. Participation in pulmonary rehabilitation programs (structured programs combining exercise, education, and support for people with lung conditions) can be beneficial for those with lung involvement[4].

Regular monitoring for complications is also important. This includes screening for pulmonary hypertension (increased pressure in the arteries of the lungs), which can develop in patients with or without concomitant interstitial lung disease[7][3].

⚠️ Important
Communication and coordination between your primary care doctor and specialists such as rheumatologists and pulmonologists are essential to expedite diagnostic testing and begin treatment early. This teamwork can significantly improve outcomes, particularly when lung disease is present.

How Antisynthetase Syndrome Affects the Body

Understanding what happens inside the body when someone has antisynthetase syndrome helps explain why symptoms occur and how they impact daily life. The syndrome involves complex changes to normal body functions that occur at the cellular and tissue level.

At the heart of the condition is the production of autoantibodies against aminoacyl-tRNA synthetases—enzymes that are crucial for protein synthesis. These enzymes help build new proteins, which are essential building blocks the body needs for virtually all its functions. When the immune system produces antibodies that attack these enzymes, it disrupts the normal process of making proteins in cells throughout the body[3][4].

In muscles, this immune attack leads to inflammation and damage to muscle fibers. The chronic inflammation causes the muscles to become weak and painful. Under a microscope, biopsies from affected muscles show characteristic patterns of inflammatory cells invading muscle tissue. The inflammation can be severe enough to cause actual breakdown of muscle tissue, releasing muscle enzymes like creatine kinase into the bloodstream—a finding that helps doctors diagnose the condition[7][3].

In the lungs, antisynthetase syndrome causes a type of damage called interstitial lung disease. The “interstitium” refers to the tissue between the air sacs and blood vessels in the lungs. When this tissue becomes inflamed and scarred, it thickens and stiffens. This makes it harder for oxygen to pass from the air sacs into the bloodstream, causing shortness of breath and reduced oxygen levels in the blood. The lungs become less stretchy and more rigid, making breathing require more effort. Over time, this can lead to progressive scarring called pulmonary fibrosis, which can be severe and sometimes rapidly progressive[3][1].

The lung disease in antisynthetase syndrome is often more prevalent and severe compared to other inflammatory muscle diseases like dermatomyositis and polymyositis. This is why interstitial lung disease causes much of the increased illness and mortality associated with antisynthetase syndrome compared to other inflammatory myopathies[3].

Joint inflammation occurs when the immune system attacks the tissues lining the joints, causing swelling, pain, and stiffness. Unlike rheumatoid arthritis, which can erode and destroy bone and cartilage, the arthritis in antisynthetase syndrome is typically non-erosive. However, some patients do show X-ray changes in their hands, including erosions and calcifications[2].

Raynaud’s phenomenon involves abnormal responses of the small blood vessels in the fingers and toes. When exposed to cold or stress, these vessels constrict excessively, dramatically reducing blood flow. This causes the characteristic color changes and uncomfortable sensations. Looking at the nail folds (the skin at the base of the fingernails) under magnification can reveal abnormalities in the tiny blood vessels, another finding associated with this syndrome[7].

The skin changes seen in mechanic’s hands involve thickening and cracking of the outer layers of skin. This occurs due to inflammation in the skin and changes in how skin cells grow and repair themselves.

The estimated cumulative ten-year survival rate for patients with different antisynthetase antibodies is 76.8 percent, suggesting that mortality is significantly higher than in the general population[2]. Progressive interstitial lung disease remains the most concerning complication, sometimes necessitating lung transplantation in severe cases. Pulmonary hypertension can develop as a complication, further compromising lung function and heart function[3][7].

Ongoing Clinical Trials on Antisynthetase syndrome

  • Study on Upadacitinib for Patients with Idiopathic Inflammatory Myopathies After Stopping IVIG

    Recruiting

    1 1
    Investigated drugs:
    Austria
  • Study on Filgotinib for Patients with Refractory Behcet’s Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet’s Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

References

https://my.clevelandclinic.org/health/diseases/25159-antisynthetase-syndrome

https://en.wikipedia.org/wiki/Antisynthetase_syndrome

https://pmc.ncbi.nlm.nih.gov/articles/PMC5006392/

https://www.myositis.org/about-myositis/complications/antisynthetase-syndrome/

https://www.aiarthritis.org/antisynthetase-syndrome-blog

https://med.uth.edu/neurosciences/antisynthetase-syndrome/

https://dermnetnz.org/topics/antisynthetase-syndrome

FAQ

Can antisynthetase syndrome be cured?

There is currently no cure for antisynthetase syndrome. However, symptoms can usually be managed with a combination of medications including immunosuppressants and corticosteroids, along with physical or pulmonary therapies. Some patients can achieve remission, especially those with milder lung disease, though they typically need to continue treatment to remain symptom-free.

How is antisynthetase syndrome diagnosed?

Diagnosis requires a multidisciplinary approach involving rheumatology and pulmonary specialists. Testing includes blood tests to detect antisynthetase antibodies, high-resolution CT scans of the chest, lung function tests, muscle enzyme measurements, and sometimes muscle or lung biopsies. The presence of antisynthetase antibodies along with characteristic symptoms helps confirm the diagnosis.

Will I have all the symptoms of antisynthetase syndrome?

No, not everyone experiences all possible symptoms. The condition affects people differently, and the combination of symptoms varies greatly from person to person. Some may primarily have lung problems, others mainly muscle weakness, and some may have multiple symptoms. The complete triad of myositis, arthritis, and interstitial lung disease occurs in only 20 to 50 percent of patients after six years of follow-up.

Can I still exercise if I have antisynthetase syndrome?

Yes, maintaining an active lifestyle is very important for people with antisynthetase syndrome, though it may be challenging when symptoms cause pain or weakness. Physical and occupational therapy can be very helpful in strengthening muscles and maintaining function. Pulmonary rehabilitation programs are beneficial for those with lung involvement. Work with healthcare providers to develop an appropriate exercise plan tailored to your specific symptoms and limitations.

Is antisynthetase syndrome hereditary?

Antisynthetase syndrome is not considered a hereditary condition in the traditional sense. While the exact cause is unknown and no specific genetic factors have been definitively identified, the condition is not passed directly from parents to children. It is an autoimmune disease where the immune system mistakenly attacks the body, but why this happens remains unclear.

🎯 Key takeaways

  • Antisynthetase syndrome is a rare autoimmune disease affecting fewer than 50,000 people in the U.S., occurring two to three times more often in women than men.
  • The condition is characterized by the presence of specific autoantibodies that attack enzymes essential for protein synthesis, though experts don’t know why this happens.
  • Lung involvement occurs in 67 to 100 percent of patients and represents the most serious complication, sometimes being the first or only symptom.
  • The classic triad of symptoms—myositis, arthritis, and interstitial lung disease—does not occur in all patients, making diagnosis challenging.
  • Early diagnosis and aggressive treatment are crucial for better outcomes, especially when lung disease is present.
  • While there is no cure, symptoms can be managed with immunosuppressive medications, corticosteroids, and supportive therapies.
  • Coordination between primary care doctors and specialists is essential for expediting diagnosis and starting appropriate treatment early.
  • The estimated ten-year survival rate is 76.8 percent, with severe interstitial lung disease being most frequently associated with early death.

Connected medications: